Cargando…
SRC and ERK cooperatively phosphorylate DLC1 and attenuate its Rho-GAP and tumor suppressor functions
SRC and ERK kinases control many cell biological processes that promote tumorigenesis by altering the activity of oncogenic and tumor suppressor proteins. We identify here a physiological interaction between DLC1, a focal adhesion protein and tumor suppressor, with SRC and ERK. The tumor suppressor...
Autores principales: | Tripathi, Brajendra K., Anderman, Meghan F., Qian, Xiaolan, Zhou, Ming, Wang, Dunrui, Papageorge, Alex G., Lowy, Douglas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719442/ https://www.ncbi.nlm.nih.gov/pubmed/31308216 http://dx.doi.org/10.1083/jcb.201810098 |
Ejemplares similares
-
CDK5 is a major regulator of the tumor suppressor DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2014) -
Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2017) -
DLC1: a tumor suppressor that regulates Rho signaling
por: Tripathi, Brajendra K., et al.
Publicado: (2017) -
Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
por: Tripathi, Brajendra K., et al.
Publicado: (2021) -
DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers
por: Wang, Dunrui, et al.
Publicado: (2016)